Patrizio Vinciarelli, 10% Owner, Director, Chairman & CEO, on June 22, 2026, sold 20,000 shares in Vicor (VICR) for $7,218,826. Following the Form 4 filing with the SEC, Vinciarelli has control over a total of 8,675,215 common shares of the company, with 8,508,090 shares held directly and 167,125 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/751978/000090148426000028/xslF345X05/ownership.xml
Price: $323.12, Change: $-13.00, Percent Change: -3.87%
Musa Tariq, Director, on June 22, 2026, sold 1,951 shares in Guardant Health (GH) for $255,893. Following the Form 4 filing with the SEC, Tariq has control over a total of 11,048 common shares of the company, with 11,048 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1576280/000196828126000018/xslF345X05/wk-form4_1782250150.xml
John D Quisel, Director, Chief Executive Officer, on June 18, 2026, sold 34,000 shares in Disc Medicine (IRON) for $2,387,296. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064 common shares of the company, with 226,064 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526279779/xslF345X05/ownership.xml
Bruce C. Taylor, Director, on June 22, 2026, executed a purchase for 100,000 shares in Mission Produce (AVO) for $1,128,269. Following the Form 4 filing with the SEC, Taylor has control over a total of 6,791,540 common shares of the company, with 755,505 shares held directly and 6,036,035 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1802974/000145935026000006/xslF345X05/wk-form4_1782248789.xml